For example, in pancreatic cancer, NEK2 phosphorylates the T194 and T210 sites of PD-L1, stimulates the glycosylation of PD-L1 at N192, N200, and N219, and prevents PD-L1 degradation[32]. This evidence concerns the gene CD274 and familial pancreatic carcinoma.